These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 374874)

  • 41. Comparative study of Mitsuda reaction to nude mouse and armadillo lepromin preparations using nine-banded armadillos.
    Job CK; Truman RW
    Int J Lepr Other Mycobact Dis; 2000 Mar; 68(1):18-22. PubMed ID: 10834065
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Microscopic findings of delayed reactions elicited by the skin test reagent Leprosin A derived from M. leprae.
    Samuel NM; Stanford JL; Desikan KV
    Int J Lepr Other Mycobact Dis; 1985 Sep; 53(3):395-403. PubMed ID: 3900246
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Histology of the Mitsuda reaction of healthy adults with no known contacts with leprosy patients.
    Petri V; Mendes EV; Beiguelman B
    Int J Lepr Other Mycobact Dis; 1985 Dec; 53(4):540-5. PubMed ID: 4086917
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Genetic component of the immune response to Mycobacterium leprae in healthy subjects].
    Bottasso OA; Hinrichsen L; Morini JC; Rabasa SL
    Medicina (B Aires); 1986; 46(6):713-8. PubMed ID: 3306256
    [No Abstract]   [Full Text] [Related]  

  • 45. Mitsuda-negative, resistant nine-banded armadillos and enhanced Mitsuda response to live M. leprae.
    Job CK; Truman RW
    Int J Lepr Other Mycobact Dis; 1999 Dec; 67(4):475-7. PubMed ID: 10700925
    [No Abstract]   [Full Text] [Related]  

  • 46. Immunological profiles of leprosy patients and healthy family contacts toward M. leprae antigens.
    Ilangumaran S; Ramanathan S; Shankernarayan N; Ramu G; Muthukkarauppan V
    Int J Lepr Other Mycobact Dis; 1996 Mar; 64(1):6-14. PubMed ID: 8627115
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A recessive major gene controls the mitsuda reaction in a region endemic for leprosy.
    Ranque B; Alcais A; Thuc NV; Woynard S; Thai VH; Huong NT; Ba NN; Khoa PX; Schurr E; Abel L
    J Infect Dis; 2005 Oct; 192(8):1475-82. PubMed ID: 16170767
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The response of the patient with leprosy toward Mycobacterium leprae injected with lepromin. A histopathologic study four hours after injection.
    Saúl A
    Int J Lepr Other Mycobact Dis; 1971; 39(2):300-7. PubMed ID: 4948077
    [No Abstract]   [Full Text] [Related]  

  • 49. Skin testing with mycobacterial reagents in leprosy.
    Stanford JL
    Tubercle; 1984 Mar; 65(1):63-74. PubMed ID: 6203199
    [No Abstract]   [Full Text] [Related]  

  • 50. ICRC vaccine-induced changes in M. leprae-specific cell-mediated immunity in langur (Presbytis entellus) monkeys.
    Chirmule NB; Deo MG; Sirodkar MV; Deshmukh R; Chanderkar NG
    Int J Lepr Other Mycobact Dis; 1986 Mar; 54(1):57-62. PubMed ID: 3519805
    [TBL] [Abstract][Full Text] [Related]  

  • 51. India carries out large-scale tests of anti-leprosy vaccine.
    Jayaraman KS
    Nature; 1987 Aug 20-26; 328(6132):660. PubMed ID: 3302728
    [No Abstract]   [Full Text] [Related]  

  • 52. Studies of reactivity of some Sri Lankan population groups to antigens of Mycobacterium leprae. I. Reactivity to lepromin A.
    Pinto MR; Eriyagama NB; Pemajayantha V
    Lepr Rev; 1987 Jun; 58(2):105-18. PubMed ID: 3302577
    [No Abstract]   [Full Text] [Related]  

  • 53. Induction of lepromin positivity following immuno-chemotherapy with Mycobacterium w vaccine and multidrug therapy and its impact on bacteriological clearance in multibacillary leprosy: report on a hospital-based clinical trial with the candidate antileprosy vaccine.
    Sharma P; Kar HK; Misra RS; Mukherjee A; Kaur H; Mukherjee R; Rani R
    Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):259-69. PubMed ID: 10575405
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sensitization and reactogenicity of two doses of candidate antileprosy vaccine Mycobacterium w.
    Gupte MD; Vallishayee RS; Anantharaman DS; Britto RL; Nagaraju B
    Indian J Lepr; 1996; 68(4):315-24. PubMed ID: 9001899
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Suppression of Mycobacterium leprae-induced leucocyte migration inhibition following lepromin injection in healthy contacts of leprosy. Preliminary observations.
    Rao SS; Stanley JN; Pearson JM
    Lepr Rev; 1985 Dec; 56(4):291-5. PubMed ID: 3908863
    [No Abstract]   [Full Text] [Related]  

  • 56. Comparison of 22 species of Mycobacteria by immunodiffusion against an absorbed reference leprosy serum.
    Gillis TP; Abe M; Bullock WE; Rojas-Espinosa O; Garcia-Ortigoza E; Draper P; Kirchheimer W; Buchanan TM
    Int J Lepr Other Mycobact Dis; 1981 Sep; 49(3):287-93. PubMed ID: 6172393
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A study of lepromin reaction in child contacts of leprosy patients and non contact children in Chengalpattu District Tamil Nadu.
    Ramu G; Dwivedi MP; Iyer CG
    Lepr India; 1980 Jul; 52(3):390-404. PubMed ID: 7206635
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The pathology of leprosy.
    Ridley DS
    Southeast Asian J Trop Med Public Health; 1978 Jun; 9(2):205-8. PubMed ID: 152980
    [No Abstract]   [Full Text] [Related]  

  • 59. Sensitization potential and reactogenicity of BCG with and without various doses of killed Mycobacterium leprae.
    Gupte MD; Anantharaman DS; De Britto RL; Vallishayee RS; Nagaraju B; Kannan S; Sengupta U
    Int J Lepr Other Mycobact Dis; 1992 Sep; 60(3):340-52. PubMed ID: 1474275
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Induction of delayed-type hypersensitivity to Mycobacterium leprae in healthy individuals.
    Smelt AH; Rees RJ; Liew FY
    Clin Exp Immunol; 1981 Jun; 44(3):501-6. PubMed ID: 7035030
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.